比較
Aars1 Related Leukoencephalopathy Cn379160 vs 2 Hydroxyadipic Aciduria C5826412
AARS1遺伝子変異による白質障害（主に神経系）と、有機酸蓄積を特徴とする代謝異常症（2-ヒドロキシアジピン酸尿症）の臨床的比較。いずれも希少でエビデンスは限られ、記載は慎重な解釈を要する。
Aars1 Related Leukoencephalopathy Cn379160
A rare genetic condition affecting the brain's white matter, caused by mutations in the AARS1 gene. It can cause movement problems, developmental delays, and other neurological symptoms.
2 Hydroxyadipic Aciduria C5826412
A metabolic condition where certain acids accumulate abnormally. It can impact energy metabolism and neurological function. Treatment typically involves dietary modifications and monitoring.
6 個の比較軸
Onset
Aars1 Related Leukoencephalopathy Cn379160
0-60
2 Hydroxyadipic Aciduria C5826412
0-null
Onset patterns differ
Severity
Aars1 Related Leukoencephalopathy Cn379160
severe
2 Hydroxyadipic Aciduria C5826412
moderate
Different severity levels
Chronic
Aars1 Related Leukoencephalopathy Cn379160
Chronic
2 Hydroxyadipic Aciduria C5826412
Chronic
Differing course
Communicable
Aars1 Related Leukoencephalopathy Cn379160
No
2 Hydroxyadipic Aciduria C5826412
No
Different transmission
Body System
Aars1 Related Leukoencephalopathy Cn379160
neurologic
2 Hydroxyadipic Aciduria C5826412
metabolic
Same/different system
Category
Aars1 Related Leukoencephalopathy Cn379160
neurologic
2 Hydroxyadipic Aciduria C5826412
metabolic
Different category
結論
aars1-related-leukoencephalopathy-CN379160 and 2-hydroxyadipic-aciduria-C5826412 differ in severity, etiology
主な鑑別ポイント
診察や検査で 2 つの疾患を最も確実に区別する所見。
| 特徴 | Aars1 Related Leukoencephalopathy Cn379160 | 2 Hydroxyadipic Aciduria C5826412 | 鑑別力 |
|---|---|---|---|
| Primary pattern | Genetic leukoencephalopathy with possible movement and developmental problems. | Abnormal accumulation of 2-hydroxyadipic acid; this alone does not confirm a diagnosis. | High |
| System emphasis | Mainly affects neurological white matter. | Mainly a metabolic abnormality that may affect energy use or neurological function. | Moderate |
| Course | Severe, chronic illness with onset reported from infancy to adulthood. | Moderate, chronic condition; the age of onset is unclear. | Low |
どちらの疾患を優先するか
Aars1 Related Leukoencephalopathy Cn379160 を選ぶ場合
MRI suggests leukoencephalopathy
White-matter disease with matching neurological features supports targeted AARS1 testing.
Moderate
AARS1 variant found
A clinically interpreted disease-causing AARS1 result favors this diagnosis over an isolated acid finding.
High
Progressive neurologic impairment
Movement or developmental concerns fit the neurological description better than aciduria alone.
Low
2 Hydroxyadipic Aciduria C5826412 を選ぶ場合
Organic-acid testing abnormal
Confirmed high 2-hydroxyadipic acid identifies the biochemical finding.
High
No white-matter diagnosis
A metabolic result should not be labeled leukoencephalopathy without supporting evidence.
Moderate
Dietary monitoring discussed
The description mentions dietary changes and monitoring, but details are not established.
Low
主な検査の違い
| 検査 | Aars1 Related Leukoencephalopathy Cn379160 | 2 Hydroxyadipic Aciduria C5826412 | 解釈 |
|---|---|---|---|
| Brain MRI | May show white-matter changes; a specialist must interpret the pattern. | No characteristic MRI finding is established. | Imaging may support neurological disease but cannot prove either condition. |
| AARS1 genetic testing | A disease-related AARS1 variant may be found. | No established AARS1 link is provided. | A clinician must classify the variant; the gene name alone is not enough. |
| Urine organic acids | No defining acid pattern is established here. | May show high 2-hydroxyadipic acid. | An abnormal metabolite may require repeat testing or broader metabolic evaluation. |
合併症の比較
| 合併症 | 所見 |
|---|---|
| Neurologic impairment | Movement problems and developmental delay are described. Neurological effects are possible but not specifically defined. Severity and permanence are unclear. |
| Metabolic disturbance | Not described as the main process. Abnormal acid buildup may affect energy use. A clinician must determine its importance. |
| Long-term disability | A severe chronic course may cause major disability. A moderate chronic impact is suggested, but outcomes are uncertain. No survival or functional outcome data are provided. |
患者教育のポイント
- HighResult versus diagnosis
An abnormal acid result does not automatically mean disease, and genetic findings need specialist interpretation.
- HighSpecialist follow-up
Neurology, genetics, or metabolic specialists should coordinate testing and monitoring.
- MediumAvoid unsupported treatments
Do not use unprescribed diets, supplements, or doses; no treatment plan is established here.